» Articles » PMID: 33045807

Recent Advances in the Diagnosis and Management of Interstitial Pneumonia with Autoimmune Features: the Perspective of Rheumatologists

Overview
Specialty General Medicine
Date 2020 Oct 13
PMID 33045807
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Interstitial pneumonia with autoimmune feature (IPAF) is a recently established disease entity that is comprised of interstitial lung diseases with evidence of autoimmune features but that does not fulfill the criteria for definite autoimmune rheumatic diseases. The classification criteria for IPAF were defined by the European Respiratory Society and American Thoracic Society in 2015. However, further studies to establish IPAF subgroups and treatment modalities for each subgroup are still needed. In this review, we discuss recent advances regarding IPAF and raise critical points for the diagnosis and management of patients with IPAF from the perspective of rheumatologists.

Citing Articles

High Interleukin-13 level is associated with disease stability in interstitial Lung disease.

Joerns E, Karp D, Zhang S, Sparks J, Adams T, Makris U Heliyon. 2024; 10(11):e32118.

PMID: 38882341 PMC: 11176841. DOI: 10.1016/j.heliyon.2024.e32118.


Nailfold capillaroscopy findings of interstitial pneumonia with autoimmune features.

Lee S, Min H, Kim S, Kim Y, Yoo K, Kim H Korean J Intern Med. 2023; 38(6):903-911.

PMID: 37488834 PMC: 10636555. DOI: 10.3904/kjim.2022.358.


Interstitial Pneumonia with Autoimmune Features: What the Rheumatologist Needs to Know.

Joerns E, Adams T, Sparks J, Newton C, Bermas B, Karp D Curr Rheumatol Rep. 2022; 24(6):213-226.

PMID: 35650373 PMC: 9159646. DOI: 10.1007/s11926-022-01072-8.

References
1.
Li Y, Zheng Z, Han Q, Li Z, Xie R, Zhang R . IPAF should receive early treatment for sharing similar clinical characteristics as CTD-ILD: a report from 273 Chinese patients. Clin Rheumatol. 2020; 39(12):3817-3823. DOI: 10.1007/s10067-020-05149-6. View

2.
Vij R, Noth I, Strek M . Autoimmune-featured interstitial lung disease: a distinct entity. Chest. 2011; 140(5):1292-1299. PMC: 3205845. DOI: 10.1378/chest.10-2662. View

3.
Schurawitzki H, STIGLBAUER R, Graninger W, Herold C, Polzleitner D, Burghuber O . Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology. 1990; 176(3):755-9. DOI: 10.1148/radiology.176.3.2389033. View

4.
Kelly B, Moua T . Overlap of interstitial pneumonia with autoimmune features with undifferentiated connective tissue disease and contribution of UIP to mortality. Respirology. 2018; 23(6):600-605. DOI: 10.1111/resp.13254. View

5.
Sambataro G, Vancheri A, Torrisi S, Colaci M, Pavone M, Libra A . The Morphological Domain Does Not Affect the Rate of Progression to Defined Autoimmune Diseases in Patients With Interstitial Pneumonia With Autoimmune Features. Chest. 2020; 157(1):238-242. DOI: 10.1016/j.chest.2019.08.2175. View